Xenon Pharmaceuticals Shares Gap Up to 33.75

XENE Stock  USD 34.46  0.32  0.92%   
About 62% of Xenon Pharmaceuticals' investor base is looking to short. The analysis of the overall investor sentiment regarding Xenon Pharmaceuticals suggests that many traders are alarmed. The current market sentiment, together with Xenon Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Xenon Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
  
Xenon Pharmaceuticals Inc. gapped up prior to trading on Thursday . The stock had previously closed at 33.75, but opened at 35.45. Xenon Pharmaceuticals shares last traded at 36.97, with a volume of 368,026 shares changing hands. Wall Street Analysts Forecast Growth XENE has been the topic of several research

Read at thelincolnianonline.com
news
  

Xenon Pharmaceuticals Fundamental Analysis

We analyze Xenon Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Xenon Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Xenon Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Debt To Equity

Debt To Equity Comparative Analysis

Xenon Pharmaceuticals is currently under evaluation in debt to equity category among its peers. Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.

Xenon Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Xenon Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Xenon Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Xenon Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Xenon Pharmaceuticals Related Equities

LYELLyell Immunopharma   5.36   
0%
100.0%
DYNDyne Therapeutics   4.80   
0%
89.0%
VRDNViridian Therapeutics   3.60   
0%
67.0%
PCVXVaxcyte   3.22   
0%
60.0%
ANABAnaptysBio   2.53   
0%
47.0%
MGTXMeiraGTx Holdings   2.21   
0%
41.0%
CRNXCrinetics Pharmaceuticals   1.13   
0%
21.0%
MRUSMerus BV   0.85   
0%
15.0%
VTYXVentyx Biosciences   0.82   
0%
15.0%
INBXInhibrx   0.56   
0%
10.0%
REPLReplimune   0.48   
0%
8.0%
IDYAIdeaya Biosciences   0.06   
1.0%
0%
KROSKeros Therapeutics   0.18   
3.0%
0%
ASNDAscendis Pharma   0.21   
3.0%
0%
NUVLNuvalent   0.42   
7.0%
0%
UTHRUnited Therapeutics   0.90   
16.0%
0%
CYTKCytokinetics   1.47   
27.0%
0%
EWTXEdgewise Therapeutics   2.37   
44.0%
0%
ACLXArcellx   2.84   
52.0%
0%
KRONKronos Bio   3.49   
65.0%
0%

Complementary Tools for Xenon Stock analysis

When running Xenon Pharmaceuticals' price analysis, check to measure Xenon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xenon Pharmaceuticals is operating at the current time. Most of Xenon Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Xenon Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xenon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Xenon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios